The lack of isolation ward throughout Japan has long been limiting the 131 I radioactive
iodine (RAI) ablation for differentiated thyroid cancer (DTC) cases. The 30 mCi RAI ablation …

This article investigates the association of the time interval between the diagnostic dose and
ablation with the stunning effect, when a 74 MBq 131 I pretherapy scanning was performed …

A diagnostic iodine-131 (131I) total body scan (TBS) is usually recommended 6 to 12
months after thyroid ablation for differentiated thyroid carcinoma. Its usefulness was …

Differentiated thyroid carcinomas are typically treated with total thyroidectomy as initial
therapy. Subsequent radioactive iodine (RAI) ablation destroys post-surgical thyroid …

The initial treatment of differentiated thyroid cancer (DTC) includes surgery, radioiodine (for
remnant ablation and/or therapy), and levothyroxine. Surgery and levothyroxine are …

Debates regarding thyroid stunning—a phenomenon whereby a diagnostic dose of
radioiodine decreases uptake of a subsequent therapeutic dose by remnant thyroid tissue or …

Background Follow-up of 131 I whole-body scanning after 131 I ablation is associated with
potential stunning. Previous studies have suggested that, for scanning, 123 I is more …

Background Management of patients with differentiated thyroid carcinoma with negative
diagnostic radioiodide scanning and increased serum thyroglobulin (Tg) concentrations is a …

Objective Postablation whole‐body scintigraphy, which is performed 5–7 days after
administration of ablation activity of radioactive iodine‐131 (131I) in patients with thyroid …

In our hospital, a 24-h radioiodine-131 (131 I) uptake-related ablation strategy is used in
patients with differentiated thyroid cancer to destroy thyroid remnants after primary surgery …